Published in Gut on November 10, 2008
Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group. J Gastroenterol (2010) 2.08
Risk factors for delayed bleeding after endoscopic submucosal dissection for gastric neoplasm. Surg Endosc (2010) 1.70
Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol (2011) 1.41
Robotic gastrectomy for gastric cancer: surgical techniques and clinical merits. Surg Endosc (2009) 1.40
Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series. Gastric Cancer (2016) 1.39
Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience. Surg Endosc (2013) 1.29
Endoscopic management of early gastric cancer: endoscopic mucosal resection or endoscopic submucosal dissection: data from a Japanese high-volume center and literature review. Ann Gastroenterol (2012) 1.18
Predictive factors for local recurrence after endoscopic resection for early gastric cancer: long-term clinical outcome in a single-center experience. Surg Endosc (2010) 1.16
Long-term efficacy of endoscopic submucosal dissection compared with surgery for early gastric cancer: a retrospective cohort study. Gut Liver (2014) 1.14
Risk factors of residual or recurrent tumor in patients with a tumor-positive resection margin after endoscopic resection of early gastric cancer. Surg Endosc (2012) 1.12
Clinical outcomes of the endoscopic submucosal dissection of early gastric cancer are comparable between absolute and new expanded criteria. Gut Liver (2015) 1.10
The current state of diagnosis and treatment for early gastric cancer. Diagn Ther Endosc (2013) 1.10
Endoscopic treatment for early gastric cancer. World J Gastroenterol (2014) 1.06
Novel strategy of endoscopic submucosal dissection using an insulation-tipped knife for early gastric cancer: near-side approach method. Endosc Int Open (2015) 1.03
Worldwide experiences of endoscopic submucosal dissection: not just Eastern acrobatics. World J Gastroenterol (2011) 1.03
Outcome of endoscopic submucosal dissection for gastric neoplasm in relationship to endoscopic classification of submucosal fibrosis. Gastric Cancer (2012) 1.01
Ex vivo pig training model for esophageal endoscopic submucosal dissection (ESD) for endoscopists with experience in gastric ESD. Surg Endosc (2012) 1.00
Endoscopic Ultrasound-Assisted Tunnel-Type Endoscopic Submucosal Dissection for the Treatment of Esophageal Tumors Arising in the Muscularis Propria (with video). Endosc Ultrasound (2013) 0.99
A new breakthrough: ESD using a newly developed grasping type scissor forceps for early gastrointestinal tract neoplasms. World J Gastrointest Endosc (2010) 0.98
High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer (2015) 0.98
MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer. PLoS One (2014) 0.97
Endoscopic submucosal dissection--current success and future directions. Nat Rev Gastroenterol Hepatol (2012) 0.97
Proton Pump Inhibitor Therapy before and after Endoscopic Submucosal Dissection: A Review. Diagn Ther Endosc (2012) 0.97
Decreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4. PLoS One (2014) 0.97
Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study. Dig Dis Sci (2011) 0.96
Future perspective of gastric cancer endotherapy. Ann Transl Med (2014) 0.94
Endoscopic submucosal dissection in the era of proton pump inhibitors. J Clin Biochem Nutr (2009) 0.93
Follow-up outcomes of endoscopic resection for early gastric cancer with undifferentiated histology. Surg Endosc (2014) 0.93
Training in endoscopic submucosal dissection. World J Gastrointest Endosc (2013) 0.93
Management of bleeding and artificial gastric ulcers associated with endoscopic submucosal dissection. World J Gastrointest Endosc (2012) 0.92
Technical issues and new devices of ESD of early gastric cancer. World J Gastroenterol (2011) 0.92
Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study. Gastric Cancer (2011) 0.92
Endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. World J Gastrointest Pathophysiol (2012) 0.91
Risk factors and management of positive horizontal margin in early gastric cancer resected by en bloc endoscopic submucosal dissection. Gastric Cancer (2014) 0.91
Clinical characteristics and management of gastric tube cancer with endoscopic submucosal dissection. World J Gastroenterol (2015) 0.91
Therapeutic Decision-Making Using Endoscopic Ultrasonography in Endoscopic Treatment of Early Gastric Cancer. Gut Liver (2016) 0.91
Technical difficulty according to location, and risk factors for perforation, in endoscopic submucosal dissection of colorectal tumors. Surg Endosc (2014) 0.91
The learning curve for endoscopic submucosal dissection in an established experimental setting. Surg Endosc (2012) 0.90
A case of local recurrence and distant metastasis following curative endoscopic submucosal dissection of early gastric cancer. Gastric Cancer (2014) 0.90
Balloon overtube-guided colorectal endoscopic submucosal dissection. World J Gastroenterol (2009) 0.90
Long-term outcome of extended endoscopic submucosal dissection for early gastric cancer with differentiated histology. Clin Endosc (2013) 0.90
Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: do we have enough data to support this? World J Gastroenterol (2014) 0.90
Treatment strategy for gastric non-invasive intraepithelial neoplasia diagnosed by endoscopic biopsy. World J Gastrointest Pathophysiol (2011) 0.89
Secondary endoscopic submucosal dissection for residual or recurrent tumors after gastric endoscopic submucosal dissection. Gastric Cancer (2013) 0.89
Endoscopic submucosal dissection of early gastric cancer. Gut Liver (2011) 0.89
A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients. BMC Cancer (2016) 0.89
Repeat endoscopic submucosal dissection for recurrent gastric cancers after endoscopic submucosal dissection. World J Gastrointest Endosc (2013) 0.88
Cost comparison between surgical treatments and endoscopic submucosal dissection in patients with early gastric cancer in Korea. Gut Liver (2015) 0.88
Clinicopathological characteristics of synchronous and metachronous gastric neoplasms after endoscopic submucosal dissection. Korean J Intern Med (2013) 0.87
Estimation by gross findings in early gastric cancer. Clin Endosc (2012) 0.87
Characteristics of gastrointestinal symptoms and function following endoscopic submucosal dissection and treatment of the gastrointestinal symptoms using rikkunshito. Exp Ther Med (2013) 0.87
Long-term clinical outcomes of endoscopic resection for early gastric cancer. Surg Endosc (2014) 0.86
Predictive factors of endoscopic submucosal dissection procedure time for gastric superficial neoplasia. World J Gastroenterol (2012) 0.86
Predictors of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer. Surg Endosc (2014) 0.86
Size discrepancy between endoscopic size and pathologic size is not negligible in endoscopic resection for early gastric cancer. Surg Endosc (2014) 0.85
Current role of minimally invasive approaches in the treatment of early gastric cancer. World J Gastroenterol (2014) 0.85
Non-curative endoscopic resection does not always lead to grave outcomes in submucosal invasive early gastric cancer. Surg Endosc (2014) 0.85
Endoscopic resection for synchronous esophageal squamous cell carcinoma and gastric adenocarcinoma in early stage is a possible alternative to surgery. Gut Liver (2015) 0.85
Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer. Surg Endosc (2015) 0.84
Endoscopic submucosal dissection for removal of superficial gastrointestinal neoplasms: A technical review. World J Gastrointest Endosc (2012) 0.84
Successful treatment of early gastric cancer adjacent to a fundal varix by endoscopic submucosal dissection and endoscopic cyanoacrylate therapy. Clin Endosc (2012) 0.84
Risk factors of developing interval early gastric cancer after negative endoscopy. Dig Dis Sci (2014) 0.84
Impact of tumor location on clinical outcomes of gastric endoscopic submucosal dissection. World J Gastroenterol (2014) 0.84
Endoscopic resection for undifferentiated early gastric cancer: focusing on histologic discrepancies between forceps biopsy-based and endoscopic resection specimen-based diagnosis. Dig Dis Sci (2014) 0.84
Risk factors for lymphatic and venous involvement in endoscopically resected gastric cancer. J Gastroenterol (2012) 0.83
A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients. Oncotarget (2016) 0.83
Characteristics and prognosis of synchronous multiple early gastric cancer. World J Gastroenterol (2013) 0.83
Endoscopic submucosal dissection for laterally spreading tumours of the colorectum in 200 consecutive cases. Surg Endosc (2010) 0.83
Endoscopic estimation of tumor size in early gastric cancer. Dig Dis Sci (2013) 0.83
Endoscopic mucosal resection and endoscopic submucosal dissection in esophageal and gastric cancers. Curr Opin Gastroenterol (2010) 0.83
Design of Japanese multicenter prospective cohort study of endoscopic resection for early gastric cancer using Web registry (J-WEB/EGC). Gastric Cancer (2012) 0.83
Endoscopic submucosal dissection for early gastric cancer in elderly patients: a meta-analysis. World J Surg Oncol (2015) 0.83
Is transnasal endoscope-assisted endoscopic submucosal dissection for gastric neoplasm useful in training beginners? A prospective randomized trial. Surg Endosc (2012) 0.82
Dehiscence following successful endoscopic closure of gastric perforation during endoscopic submucosal dissection. World J Gastroenterol (2012) 0.82
Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk. J Gastroenterol (2013) 0.82
Growth Patterns of Signet Ring Cell Carcinoma of the Stomach for Endoscopic Resection. Gut Liver (2015) 0.82
Clinical Outcomes of Endoscopic Submucosal Dissection for Superficial Esophageal Squamous Neoplasms. Clin Endosc (2016) 0.81
Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia. PLoS One (2015) 0.81
Endoscopic Resection for Early Gastric Cancer beyond Absolute Indication with Emphasis on Controversial Issues. J Gastric Cancer (2014) 0.81
Can endoscopic submucosal dissection be safely performed in a smaller specialized clinic? World J Gastroenterol (2013) 0.81
Usefulness of magnifying endoscopy with narrow-band imaging for diagnosis of depressed gastric lesions. Mol Clin Oncol (2013) 0.81
Outcomes of balloon dilation for the treatment of strictures after endoscopic submucosal dissection compared with peptic strictures. Surg Endosc (2013) 0.80
Clinical features of second primary cancers arising in early gastric cancer patients after endoscopic resection. World J Gastroenterol (2015) 0.80
Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis. PLoS One (2015) 0.80
Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan. Gastric Cancer (2015) 0.80
Additional gastrectomy after endoscopic submucosal dissection for early gastric cancer patients with comorbidities. Int J Surg Oncol (2012) 0.80
Short-Term Outcomes of Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Prospective Multicenter Cohort Study. Gut Liver (2016) 0.80
Risk factors for local recurrence after en bloc endoscopic submucosal dissection for early gastric cancer. World J Gastrointest Endosc (2016) 0.79
Endoscopic submucosal dissection for early gastric cancer: quo vadis? World J Gastroenterol (2011) 0.79
Can we apply the same indication of endoscopic submucosal dissection for primary gastric cancer to remnant gastric cancer? Gastric Cancer (2013) 0.79
Endoscopic predictors for undifferentiated histology in differentiated gastric neoplasms prior to endoscopic resection. Surg Endosc (2015) 0.79
Ever-changing endoscopic treatment for early gastric cancer: yesterday-today-tomorrow. World J Gastroenterol (2014) 0.79
Endoscopic submucosal dissection for early gastric cancer with undifferentiated-type histology: A meta-analysis. World J Gastroenterol (2015) 0.78
Solutions for submucosal injection in endoscopic resection: a systematic review and meta-analysis. Endosc Int Open (2015) 0.78
Endoscopic Resection Versus Surgical Resection for Early Gastric Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.78
Routine follow-up biopsies after complete endoscopic resection for early gastric cancer may be unnecessary. J Gastric Cancer (2012) 0.78
Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: a propensity score analysis. Surg Endosc (2014) 0.78
Management of complications following endoscopic submucosal dissection for gastric cancer. World J Gastrointest Endosc (2011) 0.78
Neutrophil infiltration and the distribution of intestinal metaplasia is associated with metachronous gastric cancer following endoscopic submucosal dissection. Can J Gastroenterol Hepatol (2015) 0.78
Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer: a meta-analysis. Gastric Cancer (2015) 0.78
Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature (1998) 4.68
Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation (1998) 4.56
Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev (2000) 4.38
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res (1991) 4.31
An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum (2008) 4.25
Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother (1996) 3.82
Disappearance and reformation of synaptic vesicle membrane upon transmitter release observed under reversible blockage of membrane retrieval. J Neurosci (1989) 3.78
Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet (1995) 3.64
Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1998) 3.57
Reversible blockage of membrane retrieval and endocytosis in the garland cell of the temperature-sensitive mutant of Drosophila melanogaster, shibirets1. J Cell Biol (1983) 3.44
Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother (1998) 3.41
Possible temperature-dependent blockage of synaptic vesicle recycling induced by a single gene mutation in Drosophila. J Neurobiol (1983) 3.36
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int (2001) 2.90
Characterization of 21 newly established esophageal cancer cell lines. Cancer (1992) 2.87
Serum lectin with known structure activates complement through the classical pathway. J Biol Chem (1987) 2.79
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med (2001) 2.74
Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? Clin Neuropathol (1985) 2.72
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology (1998) 2.67
Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex. Nature (2000) 2.60
Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery (1994) 2.45
NAK is an IkappaB kinase-activating kinase. Nature (2000) 2.44
Regional brain blood flow in man during acute changes in arterial blood gases. J Physiol (2012) 2.34
Recurrence of hepatocellular carcinoma after surgery. Br J Surg (1996) 2.27
Nested polymerase chain reaction for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol (1993) 2.27
Impairment of motor coordination, Purkinje cell synapse formation, and cerebellar long-term depression in GluR delta 2 mutant mice. Cell (1995) 2.25
Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science (1999) 2.25
Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1988) 2.20
Feasibility of stomach exploration with a guided capsule endoscope. Endoscopy (2010) 2.20
Fulminating lactose-positive Vibrio septicemia. Acta Pathol Jpn (1978) 2.20
Novel mutations in the connexin 26 gene (GJB2) responsible for childhood deafness in the Japanese population. Am J Med Genet (2000) 2.17
Synaptic vesicles have two distinct recycling pathways. J Cell Biol (1996) 2.17
Investigation of the mechanism of alcohol-induced bronchial asthma. J Allergy Clin Immunol (1996) 2.16
The long-term pathological evolution of chronic hepatitis C. Hepatology (1996) 2.15
Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene (1990) 2.14
Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J Exp Med (1999) 2.13
Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med (1989) 2.12
Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut (1998) 2.11
Six family genes--structure and function as transcription factors and their roles in development. Bioessays (2000) 2.03
Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division. Proc Natl Acad Sci U S A (1986) 1.99
Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer (2000) 1.98
Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science (1994) 1.98
Patterned neural activity of a mutant Drosophila melanogaster. Proc Natl Acad Sci U S A (1970) 1.97
Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology (1994) 1.96
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry (2004) 1.95
Characterization of T antigen in cells infected with a temperature-sensitive mutant of simian virus 40. J Virol (1975) 1.91
A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis (1993) 1.91
DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest (2001) 1.89
Molecular cloning and expression of megakaryocyte potentiating factor cDNA. J Biol Chem (1995) 1.88
Molecular cloning and expression of the murine interleukin-5 receptor. EMBO J (1990) 1.85
Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med (1988) 1.82
Clinical evaluation of 61 patients with pulmonary aspergilloma. Intern Med (2000) 1.82
Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism. N Engl J Med (1991) 1.80
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis (2007) 1.79
Synaptic transmission reversibly conditioned by single-gene mutation in Drosophila melanogaster. Nature (1976) 1.79
Flexible endoneurosurgical therapy for aqueductal stenosis. Neurosurgery (1993) 1.77
T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunol Rev (1988) 1.76
Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol (1999) 1.75
Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma. Cancer (2000) 1.73
Expression of CD7 antigen precludes t(8;21)(q22;q22) chromosome aberration in acute myeloblastic leukemia. Blood (1992) 1.72
CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol (1995) 1.72
Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J Immunol (1999) 1.71
Penetration of macrolides into human polymorphonuclear leucocytes. J Antimicrob Chemother (1989) 1.71
Relation between initial blood distribution volume and propofol induction dose requirement. Anesthesiology (2001) 1.68
Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene (1999) 1.68
Ethanol opens G-protein-activated inwardly rectifying K+ channels. Nat Neurosci (1999) 1.66
Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution. Biochemistry (1981) 1.66
Purification and characterization of a novel GTP-binding protein with a molecular weight of 24,000 from bovine brain membranes. J Biol Chem (1988) 1.66
Mobile phone use and acoustic neuroma risk in Japan. Occup Environ Med (2006) 1.66
Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli. Anesthesiology (1997) 1.66
Congenital primitive neuroectodermal tumor with epithelial and glial differentiation. An ultrastructural and immunohistochemical study. Arch Pathol Lab Med (1990) 1.65
G-language Genome Analysis Environment: a workbench for nucleotide sequence data mining. Bioinformatics (2003) 1.64
Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol (1995) 1.63
Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol (1998) 1.61
Neurofibrillary tangles and senile plaques in brain of elderly leprosy patients. Lancet (1992) 1.61
Diagnosis and treatment of Hirschsprung's disease in Japan. An analysis of 1628 patients. Ann Surg (1984) 1.61
Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med (1998) 1.61
Obesity and lipid profiles in middle aged men and women in Tanzania. East Afr Med J (2002) 1.60
Transformational process of the endosomal compartment in nephrocytes of Drosophila melanogaster. Cell Tissue Res (1990) 1.59
Short report: possible Cryptosporidium muris infection in humans. Am J Trop Med Hyg (2000) 1.59
Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor). J Biol Chem (2001) 1.58
Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun (1997) 1.57
Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol (1999) 1.57
Complications after cyst excision with hepaticoenterostomy for choledochal cysts and their surgical management in children versus adults. J Pediatr Surg (1997) 1.56
The effects of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology (1998) 1.56
Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci U S A (1997) 1.56
Electroencephalographic derivatives as a tool for predicting the depth of sedation and anesthesia induced by sevoflurane. Anesthesiology (1998) 1.55
Polyhydroxylated alkaloids isolated from mulberry trees (Morusalba L.) and silkworms (Bombyx mori L.). J Agric Food Chem (2001) 1.55
Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J Antimicrob Chemother (1999) 1.54
Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci Lett (1996) 1.53
In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives. Eur J Biochem (2000) 1.53
Traditional Chinese medicine and Kampo: a review from the distant past for the future. J Int Med Res (2006) 1.52
The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol (1994) 1.52
Uptake and biotransformation of sevoflurane in humans: a comparative study of sevoflurane with halothane, enflurane, and isoflurane. J Clin Anesth (1991) 1.51
The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs. J Antimicrob Chemother (1986) 1.51
Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy (2009) 1.51